IRCM researchers take an important step in making this
promising approach a reality
IRCM researchers, led by endocrinologist Dr. Rémi
Rabasa-Lhoret, were the first to conduct a trial comparing a dual-hormone
artificial pancreas with conventional diabetes treatment using an insulin pump
and showed improved glucose levels and lower risks of hypoglycemia. Their
results, published today in the Canadian Medical Association Journal (CMAJ),
can have a great impact on the treatment of type 1 diabetes by accelerating the
development of the external artificial pancreas.